SPRAY FORMULATION BASED ON IMMUNOGLOBIN Y ANTIBODIES HAVING TREATMENT AND PROTECTION CHARACTERISTICS FOR ALL STRAINS OF INFLUENZA A VIRUS
The present invention relates to obtaining nano-biotechnologic agent (lgY@PLGA) as a result of encapsulating with poly (lactic-co-glycolic-acid) (PLGA) which is a polymer which does not show toxic effect in the metabolism, in order to prevent specific immuno-globulin Y antibodies from fragmenting be...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | UNAL, Gokce BUDAMA KILINC, Yasemin |
| description | The present invention relates to obtaining nano-biotechnologic agent (lgY@PLGA) as a result of encapsulating with poly (lactic-co-glycolic-acid) (PLGA) which is a polymer which does not show toxic effect in the metabolism, in order to prevent specific immuno-globulin Y antibodies from fragmenting before reaching their targets in the body and in order to provide specific immuno-globulin Y antibodies to bind to the external region (M2e) of the M2 protein of the influenza A virus which is substantially well-protected and in order to provide deactivation of the viruses, and relates to application of said nano-biotechnologic agent (lgY@PLGA) in spray form.
La présente invention concerne l'obtention d'un agent nano-biotechnologique (lgY@PLGA) suite à l'encapsulation avec du poly (acide lactique-co-glycolique) (PLGA) qui est un polymère qui ne présente pas d'effet toxique dans le métabolisme, afin d'empêcher des anticorps immunoglobuline Y spécifiques de se fragmenter avant d'atteindre leurs cibles dans le corps et afin de fournir des anticorps immunoglobuline Y spécifiques à se lier à la région externe (M2e) de la protéine M2 du virus de la grippe A qui est sensiblement bien protégé et afin d'assurer la désactivation des virus, et concerne l'application dudit agent nano-biotechnologique (lgY@PLGA) sous forme de spray. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2019132847A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2019132847A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2019132847A13</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRdNYiHqHAWvBJIJaTjabZGAzG3YnEW1EZK1EhXgJb20UD2D1PrzPG0cv3zjcQ2Fd3RoUsgwZep3DMKiuW7alsRkx7AFZKLM5aQ8VdsQliNMotWYZXA6Ns6LVN6EqdKhEO_JCyn_ygMaAF4fEHmwBxIVpNR8QEDpyrZ9Go8vp2ofZj5NoXmhR1SI87sfQP07ncAvP484my3gbp8lmtcY4_e_1BtTFP_Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SPRAY FORMULATION BASED ON IMMUNOGLOBIN Y ANTIBODIES HAVING TREATMENT AND PROTECTION CHARACTERISTICS FOR ALL STRAINS OF INFLUENZA A VIRUS</title><source>esp@cenet</source><creator>UNAL, Gokce ; BUDAMA KILINC, Yasemin</creator><creatorcontrib>UNAL, Gokce ; BUDAMA KILINC, Yasemin</creatorcontrib><description>The present invention relates to obtaining nano-biotechnologic agent (lgY@PLGA) as a result of encapsulating with poly (lactic-co-glycolic-acid) (PLGA) which is a polymer which does not show toxic effect in the metabolism, in order to prevent specific immuno-globulin Y antibodies from fragmenting before reaching their targets in the body and in order to provide specific immuno-globulin Y antibodies to bind to the external region (M2e) of the M2 protein of the influenza A virus which is substantially well-protected and in order to provide deactivation of the viruses, and relates to application of said nano-biotechnologic agent (lgY@PLGA) in spray form.
La présente invention concerne l'obtention d'un agent nano-biotechnologique (lgY@PLGA) suite à l'encapsulation avec du poly (acide lactique-co-glycolique) (PLGA) qui est un polymère qui ne présente pas d'effet toxique dans le métabolisme, afin d'empêcher des anticorps immunoglobuline Y spécifiques de se fragmenter avant d'atteindre leurs cibles dans le corps et afin de fournir des anticorps immunoglobuline Y spécifiques à se lier à la région externe (M2e) de la protéine M2 du virus de la grippe A qui est sensiblement bien protégé et afin d'assurer la désactivation des virus, et concerne l'application dudit agent nano-biotechnologique (lgY@PLGA) sous forme de spray.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190704&DB=EPODOC&CC=WO&NR=2019132847A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190704&DB=EPODOC&CC=WO&NR=2019132847A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>UNAL, Gokce</creatorcontrib><creatorcontrib>BUDAMA KILINC, Yasemin</creatorcontrib><title>SPRAY FORMULATION BASED ON IMMUNOGLOBIN Y ANTIBODIES HAVING TREATMENT AND PROTECTION CHARACTERISTICS FOR ALL STRAINS OF INFLUENZA A VIRUS</title><description>The present invention relates to obtaining nano-biotechnologic agent (lgY@PLGA) as a result of encapsulating with poly (lactic-co-glycolic-acid) (PLGA) which is a polymer which does not show toxic effect in the metabolism, in order to prevent specific immuno-globulin Y antibodies from fragmenting before reaching their targets in the body and in order to provide specific immuno-globulin Y antibodies to bind to the external region (M2e) of the M2 protein of the influenza A virus which is substantially well-protected and in order to provide deactivation of the viruses, and relates to application of said nano-biotechnologic agent (lgY@PLGA) in spray form.
La présente invention concerne l'obtention d'un agent nano-biotechnologique (lgY@PLGA) suite à l'encapsulation avec du poly (acide lactique-co-glycolique) (PLGA) qui est un polymère qui ne présente pas d'effet toxique dans le métabolisme, afin d'empêcher des anticorps immunoglobuline Y spécifiques de se fragmenter avant d'atteindre leurs cibles dans le corps et afin de fournir des anticorps immunoglobuline Y spécifiques à se lier à la région externe (M2e) de la protéine M2 du virus de la grippe A qui est sensiblement bien protégé et afin d'assurer la désactivation des virus, et concerne l'application dudit agent nano-biotechnologique (lgY@PLGA) sous forme de spray.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAQRdNYiHqHAWvBJIJaTjabZGAzG3YnEW1EZK1EhXgJb20UD2D1PrzPG0cv3zjcQ2Fd3RoUsgwZep3DMKiuW7alsRkx7AFZKLM5aQ8VdsQliNMotWYZXA6Ns6LVN6EqdKhEO_JCyn_ygMaAF4fEHmwBxIVpNR8QEDpyrZ9Go8vp2ofZj5NoXmhR1SI87sfQP07ncAvP484my3gbp8lmtcY4_e_1BtTFP_Y</recordid><startdate>20190704</startdate><enddate>20190704</enddate><creator>UNAL, Gokce</creator><creator>BUDAMA KILINC, Yasemin</creator><scope>EVB</scope></search><sort><creationdate>20190704</creationdate><title>SPRAY FORMULATION BASED ON IMMUNOGLOBIN Y ANTIBODIES HAVING TREATMENT AND PROTECTION CHARACTERISTICS FOR ALL STRAINS OF INFLUENZA A VIRUS</title><author>UNAL, Gokce ; BUDAMA KILINC, Yasemin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2019132847A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>UNAL, Gokce</creatorcontrib><creatorcontrib>BUDAMA KILINC, Yasemin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>UNAL, Gokce</au><au>BUDAMA KILINC, Yasemin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SPRAY FORMULATION BASED ON IMMUNOGLOBIN Y ANTIBODIES HAVING TREATMENT AND PROTECTION CHARACTERISTICS FOR ALL STRAINS OF INFLUENZA A VIRUS</title><date>2019-07-04</date><risdate>2019</risdate><abstract>The present invention relates to obtaining nano-biotechnologic agent (lgY@PLGA) as a result of encapsulating with poly (lactic-co-glycolic-acid) (PLGA) which is a polymer which does not show toxic effect in the metabolism, in order to prevent specific immuno-globulin Y antibodies from fragmenting before reaching their targets in the body and in order to provide specific immuno-globulin Y antibodies to bind to the external region (M2e) of the M2 protein of the influenza A virus which is substantially well-protected and in order to provide deactivation of the viruses, and relates to application of said nano-biotechnologic agent (lgY@PLGA) in spray form.
La présente invention concerne l'obtention d'un agent nano-biotechnologique (lgY@PLGA) suite à l'encapsulation avec du poly (acide lactique-co-glycolique) (PLGA) qui est un polymère qui ne présente pas d'effet toxique dans le métabolisme, afin d'empêcher des anticorps immunoglobuline Y spécifiques de se fragmenter avant d'atteindre leurs cibles dans le corps et afin de fournir des anticorps immunoglobuline Y spécifiques à se lier à la région externe (M2e) de la protéine M2 du virus de la grippe A qui est sensiblement bien protégé et afin d'assurer la désactivation des virus, et concerne l'application dudit agent nano-biotechnologique (lgY@PLGA) sous forme de spray.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2019132847A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SPRAY FORMULATION BASED ON IMMUNOGLOBIN Y ANTIBODIES HAVING TREATMENT AND PROTECTION CHARACTERISTICS FOR ALL STRAINS OF INFLUENZA A VIRUS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T23%3A05%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=UNAL,%20Gokce&rft.date=2019-07-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2019132847A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |